Arovella Therapeutics Ltd News

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 29 05:11

Arovella Therapeutics Ltd: Notice Under Section 708A

Oct 18 07:15

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Oct 18 07:13

Arovella Therapeutics Ltd: Clinical Advisory Board established

Oct 14 06:47

Arovella Therapeutics Ltd: Updated Investor Webinar Presentation

Sep 12 15:18

Arovella Therapeutics Ltd: Investor Webinar Presentation

Sep 12 11:27

Arovella Therapeutics Ltd: 2024 ESG Report

Sep 11 08:32

Arovella Therapeutics Ltd: Corporate Governance Statement

Aug 22 07:46

Arovella Therapeutics Ltd: Appendix 4G

Aug 22 07:44

Arovella Therapeutics Ltd: Positive pre-IND feedback from FDA for ALA-101

Aug 7 07:21

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 25 07:34

Arovella Therapeutics Ltd: Zolpimist Update

Jun 13 06:24

Arovella Therapeutics Ltd: Arovella completes manufacturing scale-up

Jun 5 07:16

Arovella Therapeutics Ltd: Release of Shares from Escrow

May 30 06:27

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 07:51

Arovella Therapeutics Ltd: Arovella presents ALA-101 data at AACR

Apr 9 06:56

Arovella Therapeutics Ltd: Prof Gianpietro Dotti appointed to Scientific Advisory Board

Apr 3 07:18

Arovella Therapeutics Ltd: Change of Director's Interest Notice - GP

Apr 3 05:28

Arovella Therapeutics Ltd: Change of Director's Interest Notice - TD

Apr 2 05:31

Arovella Therapeutics Ltd: Change of Director's Interest Notice - MB

Mar 28 06:49